In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy.
about
PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells.The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapyThe anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibitionThe FDA approved PI3K inhibitor GDC-0941 enhances in vitro the anti-neoplastic efficacy of Axitinib against c-myc-amplified high-risk medulloblastoma.
P2860
In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@ast
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@en
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@nl
type
label
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@ast
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@en
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@nl
prefLabel
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@ast
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@en
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@nl
P2093
P2860
P356
P1433
P1476
In comparative analysis of mul ...... in vitro and in vivo efficacy.
@en
P2093
Dagmar Dilloo
Martin I Holst
Michael Ehrhardt
Rogerio B Craveiro
Thorsten Pietsch
P2860
P304
P356
10.18632/ONCOTARGET.2240
P407
P577
2014-08-01T00:00:00Z